These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22428467)

  • 1. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
    Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
    Wang CD; Teng BS; He YM; Wu JS; Pan D; Pan LF; Zhang D; Fan ZH; Yang HJ; Zhou P
    Br J Nutr; 2012 Dec; 108(11):2014-25. PubMed ID: 22453054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice.
    Teng BS; Wang CD; Yang HJ; Wu JS; Zhang D; Zheng M; Fan ZH; Pan D; Zhou P
    J Agric Food Chem; 2011 Jun; 59(12):6492-500. PubMed ID: 21585203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.
    Yang Z; Wu F; He Y; Zhang Q; Zhang Y; Zhou G; Yang H; Zhou P
    Food Funct; 2018 Jan; 9(1):397-406. PubMed ID: 29215104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B.
    Wu Y; Ou-Yang JP; Wu K; Wang Y; Zhou YF; Wen CY
    Acta Pharmacol Sin; 2005 Mar; 26(3):345-52. PubMed ID: 15715932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes.
    Pan D; Wang L; Hu B; Zhou P
    Biopolymers; 2014 Jun; 101(6):613-23. PubMed ID: 24127303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of different compatibility proportion of jiaotai pills on treating type 2 diabetes mellitus in rats].
    Wang J; Lu F; Dong H; Gong Y; Xu L; Zou X; Chen G
    Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2271-6. PubMed ID: 22097345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism.
    Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
    PLoS One; 2013; 8(7):e68332. PubMed ID: 23874589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
    Pan D; Zhang D; Wu J; Chen C; Xu Z; Yang H; Zhou P
    Food Chem Toxicol; 2014 Jan; 63():111-8. PubMed ID: 24211521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice.
    Xiao C; Wu QP; Cai W; Tan JB; Yang XB; Zhang JM
    Arch Pharm Res; 2012 Oct; 35(10):1793-801. PubMed ID: 23139131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
    Ashokkumar N; Pari L; Manimekalai A; Selvaraju K
    J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.
    Wu Y; Ouyang JP; Wu K; Wang SS; Wen CY; Xia ZY
    Br J Pharmacol; 2005 Sep; 146(2):234-43. PubMed ID: 15997237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
    Abdin AA; Baalash AA; Hamooda HE
    J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the mechanism of action of total flavonoids of Litsea coreana for reducing blood glucose level in rat with type 2 diabetes mellitus].
    Sun YX; Lu YX; Wang LY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):617-21. PubMed ID: 20815278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats.
    Sunil C; Ignacimuthu S; Agastian P
    J Ethnopharmacol; 2011 Mar; 134(2):298-304. PubMed ID: 21182925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes.
    Rajasekaran S; Ravi K; Sivagnanam K; Subramanian S
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):232-7. PubMed ID: 16487267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic activity of Ganoderma lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice.
    Xiao C; Wu Q; Zhang J; Xie Y; Cai W; Tan J
    J Ethnopharmacol; 2017 Jan; 196():47-57. PubMed ID: 27902927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.